177 related articles for article (PubMed ID: 34966410)
1. High Expression of CEMIP Correlates Poor Prognosis and the Tumur Microenvironment in Breast Cancer as a Promisingly Prognostic Biomarker.
Dong X; Yang Y; Yuan Q; Hou J; Wu G
Front Genet; 2021; 12():768140. PubMed ID: 34966410
[TBL] [Abstract][Full Text] [Related]
2.
Xue J; Zhu X; Qiao X; Wang Y; Bu J; Zhang X; Ma Q; Liang L; Sun L; Liu C
Int J Med Sci; 2022; 19(3):434-445. PubMed ID: 35370456
[No Abstract] [Full Text] [Related]
3. CEMIP, a Promising Biomarker That Promotes the Progression and Metastasis of Colorectal and Other Types of Cancer.
Domanegg K; Sleeman JP; Schmaus A
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291875
[TBL] [Abstract][Full Text] [Related]
4. Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival.
Fink SP; Myeroff LL; Kariv R; Platzer P; Xin B; Mikkola D; Lawrence E; Morris N; Nosrati A; Willson JK; Willis J; Veigl M; Barnholtz-Sloan JS; Wang Z; Markowitz SD
Oncotarget; 2015 Oct; 6(31):30500-15. PubMed ID: 26437221
[TBL] [Abstract][Full Text] [Related]
5. Central Role of CEMIP in Tumorigenesis and Its Potential as Therapeutic Target.
Li L; Yan LH; Manoj S; Li Y; Lu L
J Cancer; 2017; 8(12):2238-2246. PubMed ID: 28819426
[TBL] [Abstract][Full Text] [Related]
6. Research on the biological mechanism and potential application of CEMIP.
Liu Y; Hu G; Li Y; Kong X; Yang K; Li Z; Lao W; Li J; Zhong J; Zhang S; Leng Y; Bi C; Zhai A
Front Immunol; 2023; 14():1222425. PubMed ID: 37662915
[TBL] [Abstract][Full Text] [Related]
7. H3K27me3 loss plays a vital role in CEMIP mediated carcinogenesis and progression of breast cancer with poor prognosis.
Hsieh IY; He J; Wang L; Lin B; Liang Z; Lu B; Chen W; Lu G; Li F; Lv W; Zhao W; Li J
Biomed Pharmacother; 2020 Mar; 123():109728. PubMed ID: 31846842
[TBL] [Abstract][Full Text] [Related]
8. Cell migration inducing hyaluronidase 1 (CEMIP) activates STAT3 pathway to facilitate cell proliferation and migration in breast cancer.
Chen Y; Li L; Zhang J
J Recept Signal Transduct Res; 2021 Apr; 41(2):145-152. PubMed ID: 32757700
[TBL] [Abstract][Full Text] [Related]
9. A novel metastatic promoter CEMIP and its downstream molecular targets and signaling pathway of cellular migration and invasion in SCLC cells based on proteome analysis.
Li L; Pan Y; Mo X; Wei T; Song J; Luo M; Huang G; Teng C; Liang K; Mao N; Yang J
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2519-2534. PubMed ID: 32648226
[TBL] [Abstract][Full Text] [Related]
10. The role of CEMIP in cancers and its transcriptional and post-transcriptional regulation.
Guo S; Guo Y; Chen Y; Cui S; Zhang C; Chen D
PeerJ; 2024; 12():e16930. PubMed ID: 38390387
[TBL] [Abstract][Full Text] [Related]
11. The role of CEMIP in tumors: An update based on cellular and molecular insights.
Chen Y; Zhou H; Jiang WJ; Wang JF; Tian Y; Jiang Y; Xia BR
Biomed Pharmacother; 2022 Feb; 146():112504. PubMed ID: 34922110
[TBL] [Abstract][Full Text] [Related]
12. AMPK/GSK3β/β-catenin cascade-triggered overexpression of CEMIP promotes migration and invasion in anoikis-resistant prostate cancer cells by enhancing metabolic reprogramming.
Zhang P; Song Y; Sun Y; Li X; Chen L; Yang L; Xing Y
FASEB J; 2018 Jul; 32(7):3924-3935. PubMed ID: 29505302
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia promotes colon cancer dissemination through up-regulation of cell migration-inducing protein (CEMIP).
Evensen NA; Li Y; Kuscu C; Liu J; Cathcart J; Banach A; Zhang Q; Li E; Joshi S; Yang J; Denoya PI; Pastorekova S; Zucker S; Shroyer KR; Cao J
Oncotarget; 2015 Aug; 6(24):20723-39. PubMed ID: 26009875
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of FREM1 in breast cancer indicates favorable prognosis and high-level immune infiltration status.
Li HN; Li XR; Lv ZT; Cai MM; Wang G; Yang ZF
Cancer Med; 2020 Dec; 9(24):9554-9570. PubMed ID: 33058542
[TBL] [Abstract][Full Text] [Related]
15. Phyto-targeting the CEMIP Expression as a Strategy to Prevent Pancreatic Cancer Metastasis.
Periyasamy L; Muruganantham B; Park WY; Muthusami S
Curr Pharm Des; 2022; 28(11):922-946. PubMed ID: 35236267
[TBL] [Abstract][Full Text] [Related]
16. CEMIP upregulates BiP to promote breast cancer cell survival in hypoxia.
Banach A; Jiang YP; Roth E; Kuscu C; Cao J; Lin RZ
Oncotarget; 2019 Jul; 10(42):4307-4320. PubMed ID: 31303964
[TBL] [Abstract][Full Text] [Related]
17. CCDC88C, an O-GalNAc glycosylation substrate of GALNT6, drives breast cancer metastasis by promoting c-JUN-mediated CEMIP transcription.
Deng B; Zhang S; Zhou Y; Sun T; Zhu Y; Fei J; Li A; Miao Y
Cancer Cell Int; 2024 Jul; 24(1):237. PubMed ID: 38971758
[TBL] [Abstract][Full Text] [Related]
18. CEMIP regulates the proliferation and migration of vascular smooth muscle cells in atherosclerosis through the WNT-beta-catenin signaling pathway.
Xue Q; Wang X; Deng X; Huang Y; Tian W
Biochem Cell Biol; 2020 Apr; 98(2):249-257. PubMed ID: 32207314
[TBL] [Abstract][Full Text] [Related]
19. CEMIP (KIAA1199) induces a fibrosis-like process in osteoarthritic chondrocytes.
Deroyer C; Charlier E; Neuville S; Malaise O; Gillet P; Kurth W; Chariot A; Malaise M; de Seny D
Cell Death Dis; 2019 Feb; 10(2):103. PubMed ID: 30718510
[TBL] [Abstract][Full Text] [Related]
20. Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma.
Zhai X; Wang W; Ma Y; Zeng Y; Dou D; Fan H; Song J; Yu X; Xin D; Du G; Jiang Z; Zhang H; Zhang X; Jin B
Aging (Albany NY); 2020 Nov; 12(23):23761-23777. PubMed ID: 33197891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
